Dr. Joseph Insung Kang Jr., MD, PhD

Dr. Kang practices at CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems.

Dr. Kang's NPI, 1730354929, was assigned on April 28, 2008. Dr. Kang graduated from Loma Linda University School Of Medicine in 2008. Dr. Kang holds California license A112375.

Dr. Kang's primary practice is CHA Hollywood Presbyterian Medical Center, at 1300 N Vermont Ave, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (213) 413-3000.

Dr. Kang's primary practice is CHA Hollywood Presbyterian Medical Center in Los Angeles, California, part of CHA Health Systems. Dr. Kang is also affiliated with Loma Linda University Medical Center. The medical group on file is Chad Sila, MD, A Professional Corporation. Dmand AI also links Dr. Kang to 5 more medical groups, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kang is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kang's licenses on file in 3 states: California, Arizona and Oklahoma.

Dmand AI lists bone cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Kang treats.

CMS data shows 538 Medicare services from Dr. Kang across 10 procedure codes in 2024, for 60 Medicare patients. Medicare paid $114,750 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Dr. Kang in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have cancer, and 75% have high blood pressure. 73% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 67, with 49% women.

In 2024, Dr. Kang wrote 36 Medicare Part D claims for 21 patients. 92% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $67 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kang for performance year 2024, reported as part of a group. Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.

Dmand AI links 4 papers to Dr. Kang in 2019. Dr. Kang's most frequent co-authors are Jerry D. Slater, MD, Chung-Tsen Hsueh, MD and Mark Evan Reeves, MD.

CMS Open Payments shows 17 general payments to Dr. Kang from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $327.

Dr. Kang graduated from Loma Linda University School Of Medicine in 2008.

Dr. Kang is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.